Share on StockTwits

athenahealth (NASDAQ:ATHN) CFO Timothy M. Adams sold 30,000 shares of athenahealth stock on the open market in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $194.58, for a total value of $5,837,400.00. Following the sale, the chief financial officer now directly owns 40,327 shares of the company’s stock, valued at approximately $7,846,828. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

athenahealth (NASDAQ:ATHN) opened at 191.67 on Thursday. athenahealth has a one year low of $82.01 and a one year high of $198.39. The stock has a 50-day moving average of $149.2 and a 200-day moving average of $128.2. The company has a market cap of $7.165 billion and a P/E ratio of 2764.43.

athenahealth (NASDAQ:ATHN) last issued its quarterly earnings data on Thursday, February 6th. The company reported $0.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.45 by $0.12. The company had revenue of $171.60 million for the quarter, compared to the consensus estimate of $168.39 million. During the same quarter in the previous year, the company posted $0.29 earnings per share. The company’s revenue for the quarter was up 47.5% on a year-over-year basis. On average, analysts predict that athenahealth will post $1.08 earnings per share for the current fiscal year.

Several analysts have recently commented on the stock. Analysts at Citigroup Inc. initiated coverage on shares of athenahealth in a research note on Tuesday. They set a “buy” rating on the stock. Separately, analysts at Robert W. Baird upgraded shares of athenahealth from a “neutral” rating to an “outperform” rating in a research note on Tuesday. They now have a $255.00 price target on the stock, up previously from $135.00. They noted that the move was a valuation call. Finally, analysts at RBC Capital initiated coverage on shares of athenahealth in a research note on Thursday, February 13th. They set a “sector perform” rating and a $180.00 price target on the stock. Two analysts have rated the stock with a sell rating, nine have given a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company. athenahealth currently has an average rating of “Hold” and an average target price of $160.20.

athenahealth, Inc (NASDAQ:ATHN), is a business services company, which provides ongoing billing, clinical-related, and other related services to its customers.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.